Intervention

BPX-601

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting1

Common conditions3

Lead sponsors shown1

Clinical trials

2 shown

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has SpreadNCT07543055 · 2026-09-08

Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid TumorsNCT02744287 · 2016-11-30

Common conditions

Metastatic Castration-resistant Prostate Cancer1 Metastatic Prostate Cancer1 Prostate Cancer1

Leading sponsors

Regeneron Pharmaceuticals2

Trial status mix

RECRUITING1

TERMINATED1

Phase mix

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.